No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aspirin / therapeutic use
-
Humans
-
Janus Kinase 2 / genetics
-
Mutation
-
Risk Factors
-
Thrombocythemia, Essential / complications
-
Thrombocythemia, Essential / diagnosis*
-
Thrombocythemia, Essential / epidemiology
-
Thrombocythemia, Essential / genetics
-
Thrombosis / classification
-
Thrombosis / epidemiology
-
Thrombosis / genetics
-
World Health Organization
Substances
-
JAK2 protein, human
-
Janus Kinase 2
-
Aspirin